Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06435871
What this trial is testing

Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 55
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT01835977
What this trial is testing

Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Clinical Research Office of the Endourological Society 106
Testing effectiveness (Phase 2)Study completedNCT00116155
What this trial is testing

Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys
Testing effectiveness (Phase 2)Ended earlyNCT00953576
What this trial is testing

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 11
Not applicableLooking for participantsNCT04765150
What this trial is testing

Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification

Who this might be right for
Prostate Carcinoma
Jonsson Comprehensive Cancer Center 275
Testing effectiveness (Phase 2)Study completedNCT00417274
What this trial is testing

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Cancer
Cleveland BioLabs 31
Not applicableLooking for participantsNCT07792590
What this trial is testing

Registry for Prostate Cancer Focal Therapy

Who this might be right for
Prostate Cancer
The University of Hong Kong 200
Not applicableActive Not RecruitingNCT05266313
What this trial is testing

Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
University Hospital Center of Martinique 135
Early research (Phase 1)Study completedNCT03177460
What this trial is testing

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 33
Not applicableStudy completedNCT00252460
What this trial is testing

CT/MRI Co-registration Prostate Cancer

Who this might be right for
Prostatic Neoplasm
University Health Network, Toronto 31
Early research (Phase 1)Not Yet RecruitingNCT07783282
What this trial is testing

Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
Astellas Pharma Global Development, Inc. 56
Not applicableApproved For MarketingNCT01606982
What this trial is testing

Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Global Development, Inc.
Early research (Phase 1)Not Yet RecruitingNCT06941480
What this trial is testing

177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Who this might be right for
Neuroendocrine Tumor of the LungNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT02928432
What this trial is testing

SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

Who this might be right for
Prostate Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 26
Not applicableLooking for participantsNCT07302763
What this trial is testing

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

Who this might be right for
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Frederic Pouliot 45
Not applicableUnknownNCT03982706
What this trial is testing

Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy

Who this might be right for
Prostate Cancer
Rabin Medical Center 1,000
Not applicableEnded earlyNCT02968784
What this trial is testing

Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
InSightec 53
Not applicableLooking for participantsNCT07276438
What this trial is testing

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 186
Not applicableActive Not RecruitingNCT05830838
What this trial is testing

Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer

Who this might be right for
Malignant Prostate Neoplasm
Mayo Clinic 50
Next Page